Global Cord Blood & Tissue Banking Industry Report Market Size, Segmentation, & Forecasts, 2024 [Yahoo! Finance]
Artivion, Inc. (AORT)
Company Research
Source: Yahoo! Finance
The first transplant using cord blood-derived hematopoietic stem cells was performed in October 1988, and since that year, remarkable achievements have been made regarding research into umbilical cord blood-derived hematopoietic and progenitor cells. To date, more than 40,000 UCB transplants (UCBTs) have been performed across different geographies of the world, in both children and adults, to treat diseases that include hematologic, metabolic, immunologic, neoplastic, and neurologic disorders. There are now over 800,000 cord blood units stored in public cord blood banks and more than 6.75 million cord blood and tissue units stored within private banks worldwide. Although cord blood storage emerged as a commercial service in the early 1990s, cord tissue storage did not emerge as a commercial service until 2008, when a Taiwanese company, HealthBanks Biotech Company Ltd., began offering the service making it the first company worldwide to do so. HealthBaby, a Hong Kong based company
Show less
Read more
Impact Snapshot
Event Time:
AORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AORT alerts
High impacting Artivion, Inc. news events
Weekly update
A roundup of the hottest topics
AORT
News
- Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial ResultsPR Newswire
- Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year [Yahoo! Finance]Yahoo! Finance
- Is Artivion (AORT) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]Yahoo! Finance
- Artivion, Inc. (NYSE: AORT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $25.00 price target on the stock.MarketBeat
- ENSEMBLE ORTHOPEDICS ANNOUNCES 700TH IMPLANTATION OF ITS MINIMALLY-INVASIVE PYROCARBON INTERPOSITIONAL CMC [Yahoo! Finance]Yahoo! Finance
AORT
Earnings
- 2/15/24 - Beat
AORT
Sec Filings
- 4/1/24 - Form ARS
- 4/1/24 - Form DEFA14A
- 4/1/24 - Form DEF
- AORT's page on the SEC website